Lu Jun-Lei, Zheng Yingling, Shi Huan, Yu Jie, Shang Hong-Kai, Qian Jing
The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, 310053, Hangzhou, Zhejiang Province, China.
Department of Gynecology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, 310006, Hangzhou, Zhejiang Province, China.
Lasers Med Sci. 2025 Jun 17;40(1):284. doi: 10.1007/s10103-025-04537-1.
To compare the efficacy and safety of 5-Aminolevulinic Acid Photodynamic Therapy (5-ALA-PDT) and Loop Electrosurgical Excision Procedure (LEEP) in the treatment of cervical high grade squamous intraepithelial lesions (HSIL).
The data of 116 patients with pathologically diagnosed cervical HSIL in Hangzhou First People's Hospital from January 2020 to June 2023 were retrospectively analyzed. According to the treatment methods, they were divided into 5-ALA-PDT group (50 cases) and LEEP group (66 cases). The patients were followed up at 3 months, 6 months, and 12 months after treatment. The clinical data of the two groups were compared.
There were no significant differences in baseline data between the two groups of patients (P > 0.05). At 12-month follow-up the complete remission (CR) rate of LEEP group and 5-ALA-PDT group was 93.94% (62/66) and 86.00% (43/50) (P = 0.260), respectively. The HPV clearance rate of LEEP group and 5-ALA-PDT group was 66.67% (44/66) and 80.00% (40/50) (P = 0.112), respectively. Multivariate analysis revealed that endocervical canal involvement was a significant risk factor for 5-ALA-PDT failure (OR = 27.35, 95% CI: 3.512-43.390, P = 0.012) and persistent HPV infection (OR = 8.013, 95% CI: 2.045-36.901, P = 0.011). In terms of adverse reactions, most of the reactions in 5-ALA-PDT group were mild local reactions that could be relieved within one week. The proportion of bleeding and cervical scar formation was higher in patients in the LEEP group (P < 0.05).
5-ALA-PDT and LEEP exhibit potential similarity in efficacy in the treatment of cervical HSIL, but the former has milder adverse reactions. The involvement of the endocervical canal is a significant risk factor for both 5-ALA-PDT failure and persistent HPV infection.
比较5-氨基酮戊酸光动力疗法(5-ALA-PDT)与环形电切术(LEEP)治疗宫颈高级别鳞状上皮内病变(HSIL)的疗效及安全性。
回顾性分析2020年1月至2023年6月在杭州市第一人民医院病理诊断为宫颈HSIL的116例患者的资料。根据治疗方法,将其分为5-ALA-PDT组(50例)和LEEP组(66例)。在治疗后3个月、6个月和12个月对患者进行随访。比较两组的临床资料。
两组患者的基线数据无显著差异(P>0.05)。在12个月的随访中,LEEP组和5-ALA-PDT组的完全缓解(CR)率分别为93.94%(62/66)和86.00%(43/50)(P = 0.260)。LEEP组和5-ALA-PDT组的HPV清除率分别为66.67%(44/66)和80.00%(40/50)(P = 0.112)。多因素分析显示,宫颈管受累是5-ALA-PDT治疗失败(OR = 27.35,95%CI:3.512 - 43.390,P = 0.012)和持续性HPV感染(OR = 8.)的显著危险因素。在不良反应方面,5-ALA-PDT组的大多数反应为轻度局部反应,可在1周内缓解。LEEP组患者出血和宫颈瘢痕形成的比例较高(P<0.05)。
5-ALA-PDT与LEEP在治疗宫颈HSIL方面疗效可能相似,但前者不良反应较轻。宫颈管受累是5-ALA-PDT治疗失败和持续性HPV感染的显著危险因素。